Vendor Intelligence Report: Looktide Labs

Published 13 Jun 2026. 20-page investigative report on who is behind Looktide Labs: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 1 Finnrick lab test, Looktide Labs is 1 pass / 0 fail — an overall pass rate of 100%. That is a favorable result where the data exists, but it is a very narrow record. Tesamorelin is the only product with independent Finnrick support; the rest of the storefront should not inherit confidence from a single passed sample.

The strongest finding is not the small sample size. Missouri formation records, domain timing, and the vendor’s own analytical page create a batch-traceability conflict: COA entries carry impossible timing, batch-code prefixes point to other products, rely on placeholder imagery, and lead to missing document files. Even the tested Tesamorelin sample sits outside the public COA trail, so the one pass does not rehabilitate the vendor-supplied paperwork.

Looktide’s buyer-facing structure adds more friction than reassurance. The catalog is gated behind registration, the contact page lacks a named responsible person or physical operating address, and the refund and privacy policies retain unfinished template fields beside strong final-sale and anti-chargeback language. Ownership remains unresolved in public records, while infrastructure review flags a co-hosted affiliate-review property as a medium-confidence attribution lead rather than a proven operator identity.

For buyers, the practical read is product-specific: Tesamorelin is comparatively better-supported, while non-tested products require fresh, matching third-party documentation before relying on Looktide. The full report shows the records, screenshots, and batch logic needed to decide whether a current vial, label, and COA actually connect.

Inside the full report:

  • Appendix A — Finnrick Laboratory Data and methodology-divergence charts for the single tested product
  • Missouri Secretary of State formation record, filing history, registered-agent trail, and domain-registration timeline
  • COA-page evidence covering pre-formation issue dates, cross-assigned batch-code prefixes, placeholder thumbnails, and 404 document checks
  • Tesamorelin batch-trace comparison between Finnrick’s physical sample and the vendor’s public COA entry
  • Hostinger/WordPress infrastructure review and the thereviewlabx.com adjacent-property attribution lead
  • Refund, Privacy, and Terms captures showing unfinished placeholders and buyer-recourse language

Risk assessment

  • Fabricated COA and batch-traceability risk — high: Public COAs for CJC-1295 (No DAC) + Ipamorelin, Tesamorelin, GHK-CU, and BPC-157 + TB-500 predate formation, use mismatched batch codes, placeholder thumbnails, and 404 files.
  • Opaque ownership and operator-attribution risk — medium: Missouri filing exposes no members/managers; Porkbun/RDAP does not expose registrant; commercial registered agent and no verified Looktide social presence.
  • Refund/legal-governance risk — medium: Refund and Privacy policies retain [Insert Contact Email]/[insert number] placeholders; Terms claim gated COA/HPLC data contradicted by the COA page.